Connected Care in Europe - 4th Edition

Table of Contents

• Table of Contents
• List of Figures
• Executive summary

1. Healthcare and social care in Europe

• 1.1. Introduction
  • 1.1.1. The ageing population
  • 1.1.2. Metabolic syndrome and lifestyle-related diseases
• 1.2. Chronic diseases
  • 1.2.1. Cardiovascular diseases
  • 1.2.2. Chronic respiratory diseases
  • 1.2.3. Diabetes
• 1.3. Neurological disorders, mental disorders and physical disabilities
  • 1.3.1. Autism spectrum disorders
  • 1.3.2. Dementia
  • 1.3.3. Epilepsy
  • 1.3.4. Other disorders and disabilities
• 1.4. Healthcare and social care systems
  • 1.4.1. Healthcare systems
  • 1.4.2. Social care systems
• 1.5. The regulatory environment
  • 1.5.1. Medical device regulations
  • 1.5.2. Privacy regulations
  • 1.5.3. Standardisation

2. Traditional telecare solutions

• 2.1. Market overview
  • 2.1.1. Form factors and use cases
  • 2.1.2. Value chain
  • 2.1.3. Competitive landscape
• 2.2. Solution providers
  • 2.2.1. 9Solutions
  • 2.2.2. Althea
  • 2.2.3. Azur Soft
  • 2.2.4. Beghelli
  • 2.2.5. Careium (Doro Care)
  • 2.2.6. Chubb Community Care
  • 2.2.7. Enovation (Verklizan)
  • 2.2.8. Eurocross
  • 2.2.9. Legrand Care
  • 2.2.10. TeleAlarm Group
  • 2.2.11. Tunstall Healthcare Group
  • 2.2.12. Urmet ATE
  • 2.2.13. Vitakt Hausnotruf

3. Next-generation telecare solutions

• 3.1. Market overview
  • 3.1.1. Form factors and use cases
  • 3.1.2. Value chain
  • 3.1.3. Competitive landscape
• 3.2. Solution providers
  • 3.2.1. AceAge
  • 3.2.2. Appello
  • 3.2.3. Buddi
  • 3.2.4. Camanio
  • 3.2.5. ContinYou
  • 3.2.6. Essence Group
  • 3.2.7. Everon
  • 3.2.8. Evondos
  • 3.2.9. GTX Corp
  • 3.2.10. iZafe Group (MediRätt)
  • 3.2.11. Just Checking
  • 3.2.12. Libify
  • 3.2.13. Limmex
  • 3.2.14. Medimi
  • 3.2.15. Merck Group
  • 3.2.16. Navigil
  • 3.2.17. Oysta Technology
  • 3.2.18. Posifon
  • 3.2.19. Sensio
  • 3.2.20. Skyresponse
  • 3.2.21. SmartLife Care
  • 3.2.22. Smartwatcher
  • 3.2.23. Telegrafik
  • 3.2.24. Tellu
  • 3.2.25. Vitalbase
  • 3.2.26. Vitavanti Medical Solutions
  • 3.2.27. VIVAI Software
  • 3.2.28. Vivago
  • 3.2.29. Yorbl

4. Telehealth solutions

• 4.1. Market overview
  • 4.1.1. Form factors and use cases
  • 4.1.2. Value chain
  • 4.1.3. Competitive landscape
• 4.2. Solution providers
  • 4.2.1. Ab Medica
  • 4.2.2. Alphabet
  • 4.2.3. Apple
  • 4.2.4. Bepatient
  • 4.2.5. BT Group
  • 4.2.6. Comarch
  • 4.2.7. Dignio
  • 4.2.8. eDevice
  • 4.2.9. Hope Care
  • 4.2.10. Huma
  • 4.2.11. KPN
  • 4.2.12. Luscii
  • 4.2.13. Medixine
  • 4.2.14. MedM
  • 4.2.15. OpenTeleHealth
  • 4.2.16. S3 Connected Health
  • 4.2.17. SHL Telemedicine
  • 4.2.18. Telefónica
  • 4.2.19. Vitagroup
  • 4.2.20. Voluntis

5. Market forecasts and conclusions

• 5.1. Market trends and analysis
  • 5.1.1. PSTN switch off continues to drive the transition to IP-based telecare
  • 5.1.2. Millions of new cellular connections will be needed for connected care
  • 5.1.3. BYOD has become a common option for telehealth
  • 5.1.4. Technological developments changes the competitive landscape
  • 5.1.5. Integrated data systems are becoming increasingly important
  • 5.1.6. The digital shift enables new services and use cases
  • 5.1.7. Convergence between telecare and telehealth towards integrated care
  • 5.1.8. From frequent readings to AI-driven patient engagement
  • 5.1.9. The use of mobile telecare solutions grows
  • 5.1.10. A slowly awakening consumer market for telecare in Europe
  • 5.1.11. COVID-19 became a catalyst that took telehealth into the next growth phase
• 5.2. Market forecasts
  • 5.2.1. Traditional telecare
  • 5.2.2. Next-generation telecare
  • 5.2.3. Telehealth
• 5.3. Revenue forecasts
  • 5.3.1. Traditional telecare
  • 5.3.2. Next-generation telecare
  • 5.3.3. Telehealth

• Glossary
• List of Companies

List of Figures

• Figure 1.1: Population by age group (EU 27+3 2021-2050)
• Figure 1.2: Share of population older than 65 years (EU 27+3 1960-2050)
• Figure 1.3: Prevalence of metabolic syndrome conditions among adults (EU 27+3 2021)
• Figure 1.4: Number of people suffering from various chronic diseases (EU 27+3 2019)
• Figure 1.5 Diabetes prevalence among adults aged 20-79 by country (Europe 2021)
• Figure 1.6: Number of people suffering from dementia, ASD and epilepsy (EU 27+3 2017)
• Figure 1.7: Total and per capita healthcare expenditure by region (Europe 2019)
• Figure 1.8: Healthcare expenditure per capita by country (EU 27+3 2019)
• Figure 1.9: Long-term care expenditure by country (EU 27+3 2019)
• Figure 1.10: Elderly care expenditure by operating area (Sweden 2020)
• Figure 1.11: Long term care expenditure by item (England April 2020-March 2021)
• Figure 2.1: Analogue and digital telecare systems (EU 27+3 2021)
• Figure 2.2: Adoption of telecare services per country (EU 27+3 2021)
• Figure 2.3: Tunstall Lifeline telecare device
• Figure 2.4: The telecare value chain
• Figure 2.5: Leading providers of telecare equipment (EU 27+3 2021)
• Figure 2.6: Leading telecare solution providers per country (EU 27+3 2021)
• Figure 2.7: Overview of telecare solution providers (EU 27+3 2021)
• Figure 2.8: Eliza by Careium smartcare hub
• Figure 2.9: Number of telecare units shipped by Legrand by country (2021)
• Figure 3.1: Next-generation telecare solutions by segment (EU 27+3 2021)
• Figure 3.2: Adoption of activity monitoring solutions per country (EU 27+3 2021)
• Figure 3.3: Examples of mobile telecare devices
• Figure 3.4: Care@Home activity monitoring solution
• Figure 3.5: Dosell medication dispenser
• Figure 3.6: Compliance monitoring solution form factors
• Figure 3.7: Overview of the next-generation telecare value chain
• Figure 3.8: Overview of the next-generation telecare landscape
• Figure 3.9: Next-generation telecare solution providers
• Figure 3.10: The Evondos E300 Automatic Medicine Dispenser
• Figure 3.11: Limmex Emergency Watch
• Figure 3.12: The Navigil 580 wristwatch
• Figure 3.13: SmartLife Care's telecare alarm system
• Figure 3.14: Vivago Care 8001 watch
• Figure 4.1: Adoption of telehealth services per country (EU 27+3 2021)
• Figure 4.2: Connected medical devices and the provision of care
• Figure 4.3: Overview of the telehealth value chain
• Figure 4.4: Overview of the telehealth landscape
• Figure 4.5: Telehealth solution providers
• Figure 4.6: The bepatient.connect app
• Figure 4.7: HealthGO by eDevice
• Figure 4.8: Medixine Suite
• Figure 4.9: MedM's applications
• Figure 5.1: Analogue and digital telecare systems (EU 27+3 2021-2027)
• Figure 5.2: Cellular connections in the connected care market (EU 27+3 2021-2027)
• Figure 5.3: Connected care systems (EU 27+3 2021-2027)
• Figure 5.4: Traditional telecare systems (EU 27+3 2021-2027)
• Figure 5.5: Next-generation telecare systems (EU 27+3 2021-2027)
• Figure 5.6: Telehealth users (EU 27+3 2021-2027)
• Figure 5.7: Connected care market revenues (EU 27+3 2021-2027)
• Figure 5.8: Traditional telecare market revenues (EU 27+3 2021-2027)
• Figure 5.9: Next-generation telecare market revenues (EU 27+3 2021-2027)
• Figure 5.10: Telehealth market revenues (EU 27+3 2021-2027)